This test is used to help diagnose chronic myelogenous leukemia (CML) or a type of acute lymphoblastic leukemia (ALL). To monitor treatment and recurrence of disease.
This Test Includes
BCR-ABL (9:22) Qualitative
Total parameters available: 1
Soft Copy (Portal/Email) : If the sample is collected before 12 noon then the report will get delivered as per Reporting Time / Maximum TAT (Turn Around Time) indicated with the test. For samples collected after 12 Noon, 12 hours may be added to the Report Turn Around TimeHard Copy : Delivered at home upon request. A small convenience fee may apply.
Why it is Done
To help diagnose and monitor the treatment of chronic myelogenous leukaemia (CML) and a type of acute lymphoblastic leukaemia (ALL).
What is this test
BCR-ABL1 refers to a sequence found in an abnormal chromosome 22 of some people with certain forms of leukaemia. Unlike most cancers, the cause of chronic myelogenous leukaemia (CML) and some other leukaemia can be traced to a single, specific genetic abnormality in one chromosome.